In this story I am going to address all ongoing Celanese shareholders. I will look into why despite ongoing dip, the longer-term fundamental drivers of the firm are still sound. What is Celanese Target Price Odds to finish over Current Price? Pertaining to normal probability distribution, the odds of Celanese to move above current price in 30 days from now is under 4%. The Celanese Corporation probability density function shows the probability of Celanese Stock to fall within a particular range of prices over 30 days . Allowing for the 30-days total investment horizon, the stock has beta coefficient of 1.3288 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average . However, if the benchmark returns are expected to be negative, Celanese will likely underperform. Additionally, the company has an alpha of 0.0544 implying that it can potentially generate 0.0544% excess return over S&P 500 after adjusting for the inherited market risk (beta).
This firm reports 3.87B of total liabilities with total debt to equity ratio (D/E) of 112.5 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Celanese dividends can provide a clue to current valuation of the stock. The firm one year expected dividend income is about $1.0 per share. Earning per share calculations of the stock is based on official Zacks consensus of 6 analysts regarding Celanese future annual earnings. Given the historical accuracy of 90.72%, the future earnings per share of the company is estimated to be 6.614 with lowest and highest values of 6.55 and 6.68 respectively. Please note that this consensus of annual earnings estimates for the organisation is an estimate of EPS before non-recurring items and including employee stock options expenses.
Annual and quarterly reports issued by Celanese are formal
financial statements that are published yearly and quarterly and sent to Celanese stockholders. The reports show and break down the current year's ongoing operations and discuss plans for the upcoming year. Annual reports have been a requirement from the
Securities and Exchange Commission (SEC) for businesses owned by the public since 1934.
Companies such as Celanese often view their annual report as an effective marketing tool to disseminate their perspective on company
future earnings or innovations. With this in mind, many companies devote large sums of money to making their reports attractive and informative. In such instances, the annual report becomes a forum through which a company can communicate to the general public any number of topics that may or may not be directly related to the actual data published in the reports.
Celanese
financial leverage refers to using borrowed capital as a funding source to finance Celanese ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Celanese financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Celanese's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Celanese's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Celanese's total debt and its cash.
The company reports 3.87B of total liabilities with total debt to equity ratio (D/E) of 112.5 which implies that Celanese may not be able to produce enough cash to satisfy its debt commitments. Celanese has Current Ratio of 1.55 which is generally considered normal. The modest gains experienced by current holders of Celanese could raise concerns from investors as the firm closed today at a share price of
107.84 on
573614.000 in volume. The company executives have been quite successful with maneuvering the stock at opportune times to take advantage of all market conditions in
March. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.9991. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. Celanese preserves 12.27x of price to earning. Celanese is trading at 108.56. This is 0.13 percent decrease. Today lowest is 107.84. Celanese Total Debt USD is increasing over the last 5 years. The previous year value of Celanese Total Debt USD was 3,684,552,632. Also, Celanese Investments Current is rather stable at the moment.
| 2014 | 2015 | 2016 | 2018 | 2019 (projected) |
Celanese Cost of Revenue | 5,186,000,000 | 4,356,000,000 | 3,984,000,000 | 3,585,600,000 | 3,893,122,807 | Celanese Consolidated Income | 620,000,000 | 285,000,000 | 906,000,000 | 815,400,000 | 638,842,105 |
Taking everything into account, our analysis show that Celanese Actively responds to market. The firm is
fairly valued and projects probability of distress
below average for the next 2 years. Our actual 'Buy vs. Hold vs. Sell' recommendation on the firm is
Strong Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEllen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Celanese. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com